Benefit with anti-PD-L1

被引：0
|
作者：
Diana Romero
机构：
来源：
Nature Reviews Clinical Oncology | 2017年 / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：71 / 71
相关论文
共 50 条
  • [31] Structural basis of the therapeutic anti-PD-L1 antibody atezolizumab
    Zhang, Fei
    Qi, Xiaoqiang
    Wang, Xiaoxiao
    Wei, Diyang
    Wu, Jiawei
    Feng, Lingling
    Cai, Haiyan
    Wang, Yugang
    Zeng, Naiyan
    Xu, Ting
    Zhou, Aiwu
    Zheng, Ying
    ONCOTARGET, 2017, 8 (52) : 90215 - 90224
  • [32] Anti-PD-L1 Treatment Induced Central Diabetes Insipidus
    Zhao, Chen
    Tella, Sri Harsha
    Del Rivero, Jaydira
    Kommalapati, Anuhya
    Ebenuwa, Ifechukwude
    Gulley, James
    Strauss, Julius
    Brownell, Isaac
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (02): : 365 - 369
  • [33] A rare case of pneumocystosis under anti-PD-L1 therapy
    Santos, Maria Joao
    Cavaco, Maria Joao
    Santos, Fernanda Paula
    Froes, Filipe
    PULMONOLOGY, 2024, 30 (06): : 671 - 672
  • [34] Anti-PD-L1 antibody active in metastatic bladder cancer
    Brower, Vicki
    LANCET ONCOLOGY, 2015, 16 (01): : E11 - E11
  • [35] A Novel Anti-PD-L1 Vaccine for Cancer Immunotherapy and Immunoprevention
    Chen, Jie
    Liu, Hui
    Jehng, Tiffany
    Li, Yanqing
    Chen, Zhoushi
    Lee, Kuan-Der
    Shen, Hsieh-Tsung
    Jones, Lindsey
    Huang, Xue F.
    Chen, Si-Yi
    CANCERS, 2019, 11 (12)
  • [36] Impact of Glucocorticoids on the Gut Microbiome with or without Anti-PD-L1
    Tsementzi, D.
    Buchwald, Z. S.
    Qiu, L.
    Khan, M. K.
    Konstantinidis, K.
    Bruner, D. W.
    Lin, J. Y., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E667 - E667
  • [37] Dynamic changes of plasma PD-L1 mRNA expression is associated with anti-PD-1/anti-PD-L1 response in malignancies
    Yang, Q.
    Chen, M.
    Gu, J.
    Zheng, L.
    Yu, Y.
    Li, F.
    Zhang, L.
    Niu, K.
    Sun, J.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1777 - 1778
  • [38] Discovery of small anti-PD-L1 peptides for cancer immunotherapy
    Liu, Hao
    Zhao, Zhen
    Li, Yuanke
    Cheng, Kun
    CANCER RESEARCH, 2019, 79 (13)
  • [39] In anti-PD-L1 immunotherapy FcγR interaction can add additional benefit depending on the tumor model
    Verbeek, J. S.
    Sow, H. S.
    Benonisson, H.
    Breukel, C.
    Visser, R.
    Verhagen, O.
    Bentlage, A.
    Brouwers, C.
    Claassens, J.
    Linssen, M.
    Camps, M.
    van Hall, T.
    Ossendorp, F.
    Herbert-Fransen, M.
    Vidarsson, G.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1733 - 1734
  • [40] Anti-PD-1 and Anti-PD-L1 in Head and Neck Cancer: A Network Meta-Analysis
    Botticelli, Andrea
    Cirillo, Alessio
    Strigari, Lidia
    Valentini, Filippo
    Cerbelli, Bruna
    Scagnoli, Simone
    Cerbelli, Edoardo
    Zizzari, Ilaria Grazia
    Rocca, Carlo Della
    D'Amati, Giulia
    Polimeni, Antonella
    Nuti, Marianna
    Merlano, Marco Carlo
    Mezi, Silvia
    Marchetti, Paolo
    FRONTIERS IN IMMUNOLOGY, 2021, 12
12345